✦ LIBER ✦

1468 POSTER A phase 1B, open-label, dose-escalation study of bortezomib (Btz) in combination with gemcitabine (G) and cisplatin (C) in the first-line treatment of patients with advanced solid tumors: preliminary results

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

365 A Phase 1b Open-label, Dose-escalati

✍ Lolkema, M.; Leong, S.; Voest, E.; Freas, E.; Shankar, G.; Brachmann, R.K.; Moss 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Rilotumumab in combination with epirubic

✍ Iveson, Timothy; Donehower, Ross C; Davidenko, Irina; Tjulandin, Sergey; Deptala 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 339 KB

605 A Phase 1, Open-label, Dose-escalati

✍ Burris, H.; Hart, L.; Kurkjian, C.; Berk, G.; Lipman, P.; Patel, C.; Rommel, C.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

The insulin-like growth factor-I recepto

✍ Molife, L R; Fong, P C; Paccagnella, L; Reid, A H M; Shaw, H M; Vidal, L; Arkena 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 469 KB

282 POSTER Preliminary results of a Phas

✍ P. Schöffski; H. Dumez; S.F. Jones; C. Fowst; P. Gerletti; H. Xu; J. Jakubczak; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 64 KB

411 POSTER A phase I, open-label, dose-e

✍ R. Salgia; A. Peterson; S. Eppler; W. Yu; B. Polite; D. Geary; E. Wesolowski; M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB